{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:22:20Z","timestamp":1790461340379,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":11317,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1981,8]]},"abstract":"<jats:p>1 Cardiac, neuromuscular (tremor) and pulmonary effects of multiple single oral doses of clenbuterol (40, 60 and 80 micrograms) and terbutaline (2.5 and 5 mg) were compared with placebo in thirteen patients with reversible obstructive airways disease. 2 The percent change in the bronchodilator and neuromuscular effects of clenbuterol and terbutaline were greater than that of the cardiac activity. 3 Both drugs decreased T wave amplitude and occasionally caused J point ST segment depression. These changes were considered typical of this class of drugs and clinically insignificant. 4 While these drugs had comparable cardiac, pulmonary and neuromuscular effects, clenbuterol, at larger doses, had a higher incidence of transient headaches and nervousness.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1981.tb01200.x","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T01:18:46Z","timestamp":1450315126000},"page":"195-200","source":"Crossref","is-referenced-by-count":23,"title":["Cardiac, pulmonary and neuromuscular effects of clenbuterol and terbutaline compared with placebo."],"prefix":"10.1111","volume":"12","author":[{"given":"TL","family":"Whitsett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CV","family":"Manion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MF","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.32.6.717"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00609979"},{"key":"e_1_2_1_4_1","first-page":"353","article-title":"An analysis of the time\u2010relations of electrocardiograms","volume":"7","author":"BAZETT H.C.","year":"1920","journal-title":"Heart"},{"key":"e_1_2_1_5_1","first-page":"589","article-title":"Dose\u2010response study of a new oral bronchodilator, NAB 365 (clenbuterol)","volume":"16","author":"BRUSASCO V.","year":"1978","journal-title":"Int. J. clin. Pharmac."},{"key":"e_1_2_1_6_1","first-page":"465","article-title":"The actue bronchodilator effect of intravenously injected clenbuterol","volume":"25","author":"CURTI P.A.","year":"1979","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_7_1","first-page":"376","article-title":"Dose\u2010response of patients with reversible bronchospasm to oral clenbuterol: four doses compared","volume":"22","author":"BONO N.","year":"1979","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_8_1","first-page":"1404","article-title":"Pharmacologisches Wirkungsprofil von NAB 365 (clenbuterol), einum nieuen Broncholytikum mit einer selektiven Wirkung auf die adrenergen beta2\u2010Rezeptoren","volume":"26","author":"ENGLEHARDT G.","year":"1976","journal-title":"Arzneim-Forsch."},{"key":"e_1_2_1_9_1","first-page":"633","article-title":"Trial of new bronchodilator, terbutaline, in asthma","volume":"4","author":"FREEDMAN B.J.","year":"1975","journal-title":"Br. med. J."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105661"},{"key":"e_1_2_1_11_1","first-page":"97","article-title":"Klinische Prufung von Bronchospasmolytika in kombinierter alternierender Versuchsonordnung","volume":"13","author":"KAIK G.","year":"1976","journal-title":"Int. J. clin. Pharmac."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1977.tb00669.x"},{"key":"e_1_2_1_13_1","first-page":"5","article-title":"Tremor caused by sympathomimetics is mediated by beta2\u2010adrenoreceptors","volume":"58","author":"LARSSON S.","year":"1977","journal-title":"Scand. J. resp. Dis."},{"key":"e_1_2_1_14_1","first-page":"69","article-title":"The beta\u20102 sympathomimetic aerosols in the treatment of asthma","volume":"35","author":"LEIFER K.N.","year":"1975","journal-title":"Ann. Allergy"},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1152\/jappl.1950.3.5.235","article-title":"Electrocardiographic effects of arterenol and isopropylarterenol in man, with a note on the auricular T wave","volume":"3","author":"LITTMAN A.","year":"1950","journal-title":"J. appl. Physiol"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(80)90746-2"},{"key":"e_1_2_1_17_1","first-page":"321","article-title":"Evaluation of cardiovascular effects and skeletal muscle tremor after acute oral administration of clenbuterol, a new bronchodilator drug, to normal human subjects","volume":"23","author":"MAZZOLA C.","year":"1978","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_18_1","first-page":"473","article-title":"The cardiovascular effects of intravenous clenbuterol (NAB 365) and ter\u2010butaline, two selective \u03b22\u2010adrenoceptors agonists","volume":"25","author":"PASOTTI C.","year":"1979","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_19_1","volume-title":"Intensive and rehabilitative respiratory care","author":"PETTY T.L.","year":"1970"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0007-0971(70)80047-X"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00567113"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(62)90059-5"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197709012970905"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1037\/11774-000"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197511062931902"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1981.tb01200.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1981.tb01200.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1981.tb01200.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:07:49Z","timestamp":1699718869000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1981.tb01200.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,8]]}},"alternative-id":["10.1111\/j.1365-2125.1981.tb01200.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01200.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,8]]}}}